Financing will help drive Syntegra’s mission of accelerating data-centric research and innovation through AI-generated synthetic data
Syntegra, a leader in synthetic healthcare data generation, announced it has closed its seed financing, bringing in a total of $5.625 million. Syntegra’s investors include Sweat Equity Ventures, Hike Ventures, Innovation Global Capital, Wisconn Valley Ventures, Village Global, Impact Venture Capital, GRIDS Capital, Berkeley Catalyst Fund, Launchpad Capital, Vastly Valuable Ventures and First Spark Ventures.
Read More: SalesTechStar Interview With Jeremey Donovan, Head Of Revenue Strategy At Salesloft
The funding will allow Syntegra to commercialize new and ongoing work with health systems, payers, life science and digital health companies, advancing data-driven innovation with its synthetic data solutions. It will also enable the growth of the Syntegra Medical Mind, the company’s ever-expanding, pre-trained model, which has now trained on over 10 million records and enables the creation of built-for-purpose synthetic datasets.
In the past year, Syntegra has more than tripled its customer base and partnered with key leaders in healthcare, technology and data privacy to explore the nearly endless possibilities for synthetic healthcare data in clinical research, analytics and AI model development.
“Synthetic data has the potential to dramatically transform the way clinical information is shared and utilized by multiple researchers in healthcare,” said Michael D. Lesh, SM MD FACC, Syntegra Founder and CEO. “This funding provides Syntegra with the capital required to fulfill our mission of accelerating innovation by making data more easily available to researchers. The investors we have chosen all add strategic insights that multiply the value of the capital.”
“Synthetic data is at the forefront of innovation and change in healthcare,” said Guy Perelmuter, Founder, GRIDS Capital. “We’re excited to back the Syntegra team and their distinctive, AI-enabled approach to synthetic data generation, which holds tremendous potential to unlock the vast amounts of data held up in silos across the healthcare industry that can be used to accelerate research and analytics.”
Read More: Nutanix Announces Elimination Of Dual-Class Stock Structure
“Syntegra is addressing a major challenge in healthcare today – bridging the gap between data access and data privacy to enable greater use of data that will bring more medical advances directly to patients,” said Daniel Portillo, Founder and Managing Partner, Sweat Equity Ventures. “We’re thrilled to be working closely with Syntegra as they advance their vision of democratizing healthcare data through their groundbreaking approach to synthetic data generation.”